SlideShare a Scribd company logo
1 of 1
PO 1021
ABSTRACT
Rationale: Chemokine receptors are involved in the recruitment of T
lymphocytes to sites of infection and inflammation. CCR4 and
CXCR3 expression has been associated with Th2 and Th1 immune
responses respectively. We examined the expression of the
chemokine receptors CCR4 and CXCR3 on CD3+ cells after allergen
and diluent challenge in the skin.
Methods: Skin biopsies were obtained from atopic allergic and non-
atopic individuals after allergen PPD and diluent challenge.
Biopsies were examined for CD3+CCR4+ cells and CD3+CXCR3+
cells using dual immunofluorescence and IL-4 and IFN-γ mRNA
expressing cells using in situ hybridisation.
Results: Following allergen challenge there was a significant
increase in CD3+/CCR4+ cell numbers within the atopic group
(p<0.001) and not in the non-atopics (p=0.28). Both atopics and non
atopics showed an increase in CD3+/CXCR3+ cells at 48 hours after
PPD challenge (p=0.01 and p=0.06 respectively). Furthermore IL-4
mRNA+ cells peaked at 8 hours after allergen challenge while IFNg
mRNA+ cells were elevated after PPD challenge at 48 hours, with no
change in the nonatopics.
Conclusion: These data suggest that, in vivo, in man CCR4 recruits
Th2 cells to the skin in the late response to specific allergen,
whereas CXCR3 recruits Th1 cells to the skin in response to PPD
challenge.
Figure 6: IL-4 mRNA and IFN-γ mRNA expressing
cells after (8hr & 48hr) allergen and PPD challenge
BACKGROUND
The recruitment of Th2 lymphocytes is recognised to play a
central role in the pathogenesis of allergic conditions.
Chemokine receptor expression on T cells has been shown to
control both their cellular arrest within the vascular
compartment through the up regulation of integrin molecules
and their subsequent migration within the extravascular space.
METHODS
Figure 3: CD3+expressing CCR4
(8 hr) after Ag and PPD challenge
CONCLUSIONS
Figure 7: Relationship between IL-4 mRNA & CCR4
expressing cells and IFN-γ mRNA & CXCR3 expressing
cells
PATIENTS
Sixteen atopics with summer hayfever, as defined by their history
and positive skin prick test (median 8.0mm, IQ (5, 10)) to grass
pollen were recruited to this study. The median age was 27 yrs (IQ,
24, 29) and M:F, 11:5. The serum concentrations of total IgE was
(median 171IU/L ( IQ 42, 720)) and allergen specific IgE 24.0 IU/L
(IQ 13, 79). Each subject underwent intradermal challenge to the
extensor surface of the forearms with Tuberculin PPD (10
Tuberculin Units in 0.02ml), allergen (10 Biological Units in 0.02ml
Phleum pratense or house dust mite extract) and diluent. The size of
the late phase response was recorded eight and 48 hours after
injection and a 4mm skin punch biopsy was taken under local
anaesthetic.
AIMS
To determine:
a) the expression of chemokine receptors CCR4 and CXCR3 on
CD3+ cells in the skin following allergen and PPD challenge
respectively
b) IL-4 and IFN-γ mRNA expressing cells as putative markers of
Th2 and Th1 cells, respectively
CCR4 and CXCR3 on CD3+ Cells in the Skin following allergen and PPD
challenge in atopic and non-atopic individuals
SC Martins, GK Banfield, H Watanabe, KT Nouri-Aria, K Furukido, CM Lloyd, DS Robinson SR Durham
Upper Respiratory Medicine, National Heart & Lung Institute, and Leukocyte Biology, Imperial College London, Manresa Road, London SW3 6LR, United Kingdom.
Allergen
Dil. 8 hrs 48 hrs
0
10
20
30
40
50
mRNA+cells/mm2
IL-4
IFN-γ
PPD
0
5
10
15
20
Dil. 8 hrs 48 hrs
mRNA+cells/mm2
IL-4
IFN-γ
CD3+
/CXCR3+
CD3+
/CCR4+
Dual staining
0
20
40
60
80
100
Ag8 PPD8 Ag48 PPD48
%CCR4+
CXCR3+
cells
%double
%CXCR3
%CCR4
-20 0 20 40 60 80
CXCR3 +ve cells/mm2
0
10
20
30
IFN-γmRNA+vecells/mm2
r=0.61
p=0.03
Skin (PPD 48)
0 20 40 60 80 100
CCR4 +ve cells/mm
2
0
20
40
60
80
100
IL-4mRNA+vecells/mm2
r=0.64
p=0.01
Skin (Ag8)
IL-4 mRNA vs CCR4 IFN-γ mRNA vs CXCR3
In a study of human cutaneous allergen-induced late responses (8hr) and tuberculin-induced
delayed responses (48) hr, in which each subject acted as his/her own control:
- CCR4 is increased on T cells at 8hr after allergen, correlates with IL-4 expression and is a
phenotypic marker of Th2 cells
- CXCR3 is increased on T cells at 48hrs after tuberculin challenge, correlates with IFN-γ
expression and is a phenotypic marker of Th1 cells
- These studies demonstrate that CCR4 is a potential therapeutic target for allergic diseases
in man
Table 1: CD3+/CCR4+, CD3+/CXCR3+ and cytokine mRNA expressing cells (IL-4 & IFN-γ)/mm2
Five micron acetone fixed sections were examined for the
proportion of CD3+CCR4+, CD3+CXCR3+ and the co-expression
of CCR4 and CXCR3 cells using dual immunofluorescence.
Six micron paraformaldehyde sections were used for detection
of IL-4 and IFN-γ mRNA expressing cells were determined by
In situ hybridisation.
STATISTICAL ANALYSIS
Figure 5: %CCR4+, CXCR3+ and CCR4+CXCR3+
cells (8hr & 48hr) after Ag and PPD challenge
The Mann-Whitney U test was used for comparison between
allergen and PPD challenge. Wilcoxon Matched-pairs signed-
rank test was used for within subject analysis. The Spearman
rank test was used to correlate the numbers of IL-4 mRNA
expressing cells with CCR4+ cells and IFN-γ mRNA expressing
cells with CXCR3+ cells ACKNOWLEDGMENT
This work is sponsored by Imperial College Trust Fund with the support of GlaxoSmithKline
Figure 1: Skin section demonstrating
CD3+CCR4+ cells (Ag 8hr)
Figure 2: Skin section demonstrating
CD3+CXCR3+ cells (PPD 48hr)
Figure 4: CD3+expressing CXCR3
(48 hr) after Ag and PPD challenge
Dil. Ag
(8hr)
Ag
(48hr)
P
values
Dil. PPD
(8hr)
PPD
(48hr)
P
values
CD3+
/CCR4+
cells
7.6±1.4 40.5±6*** 35±9.5** 0.000
0.009
18.7±7.7 7.7±1.6 53.8±13.6* 0.02
CD3+
/CXCR3+
cell
0.5±0.26 2.5±0.75* 0.8±0.45 0.04
0.7
3.9±3.4 1.3±0.47 20±5.6* 0.01
0.4
IL-4 mRNA+
cells
1.0±0.53 36.9±10.8* 19.9±8.5* 0.001 1.65±0.8 1.88±1.2 2.68±1.4 0.9
0.6
IFN-γ mRNA+
cells
0.57±0.2 6.5±1.1* 5.5±0.9* 0.001
0.001
0.44±0.2 1.7±0.5* 10.3±2.3** 0.03
0.003
Data are shown as mean±SEM
Dil 48hr
Ag
0
10
20
30
CD3+/CXCR3+cells/mm
2
Dil 48hr
PPD
p=0.7 p=0.03
p=002
(74)
(57)
(57)
(55)
Dil 8hr
Ag
0
20
40
60
80
100
CD3+/CCR4+cells/mm
2
Dil 8hr
PPD
p=0.0000 p=0.1
p=0.000
(126)

More Related Content

Similar to CKRBSACI 2005 SM

AACR Immune Infiltration In ER, PR, HER2 IHC Subtypes
AACR Immune Infiltration In ER, PR, HER2 IHC SubtypesAACR Immune Infiltration In ER, PR, HER2 IHC Subtypes
AACR Immune Infiltration In ER, PR, HER2 IHC Subtypes
Rafael Casiano
 
William Kay YIG 2
William Kay YIG 2William Kay YIG 2
William Kay YIG 2
William Kay
 

Similar to CKRBSACI 2005 SM (20)

Contact dermatitis
Contact dermatitisContact dermatitis
Contact dermatitis
 
Asthma epigenomics
Asthma epigenomicsAsthma epigenomics
Asthma epigenomics
 
430_2008_Article_81
430_2008_Article_81430_2008_Article_81
430_2008_Article_81
 
AACR Immune Infiltration In ER, PR, HER2 IHC Subtypes
AACR Immune Infiltration In ER, PR, HER2 IHC SubtypesAACR Immune Infiltration In ER, PR, HER2 IHC Subtypes
AACR Immune Infiltration In ER, PR, HER2 IHC Subtypes
 
Zeine & Owens, J. Neuroimmunology 1993
Zeine & Owens, J. Neuroimmunology 1993Zeine & Owens, J. Neuroimmunology 1993
Zeine & Owens, J. Neuroimmunology 1993
 
The Roles Of iNKT Cells In Asthma
The Roles Of iNKT Cells In AsthmaThe Roles Of iNKT Cells In Asthma
The Roles Of iNKT Cells In Asthma
 
Asthma epigenomics
Asthma epigenomicsAsthma epigenomics
Asthma epigenomics
 
MInh Project 2
MInh Project 2MInh Project 2
MInh Project 2
 
CIV retreat
CIV retreatCIV retreat
CIV retreat
 
Vitiligo as os autoimmune disease
Vitiligo as os autoimmune diseaseVitiligo as os autoimmune disease
Vitiligo as os autoimmune disease
 
JCI9908476
JCI9908476JCI9908476
JCI9908476
 
William Kay YIG 2
William Kay YIG 2William Kay YIG 2
William Kay YIG 2
 
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
 
HIV Cure by Stem cell transplantation
HIV Cure by Stem cell transplantationHIV Cure by Stem cell transplantation
HIV Cure by Stem cell transplantation
 
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo RuizLack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
 
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptxHYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
 
tansgenic mice:methodology and application
tansgenic mice:methodology and applicationtansgenic mice:methodology and application
tansgenic mice:methodology and application
 
L372.full
L372.fullL372.full
L372.full
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 

CKRBSACI 2005 SM

  • 1. PO 1021 ABSTRACT Rationale: Chemokine receptors are involved in the recruitment of T lymphocytes to sites of infection and inflammation. CCR4 and CXCR3 expression has been associated with Th2 and Th1 immune responses respectively. We examined the expression of the chemokine receptors CCR4 and CXCR3 on CD3+ cells after allergen and diluent challenge in the skin. Methods: Skin biopsies were obtained from atopic allergic and non- atopic individuals after allergen PPD and diluent challenge. Biopsies were examined for CD3+CCR4+ cells and CD3+CXCR3+ cells using dual immunofluorescence and IL-4 and IFN-γ mRNA expressing cells using in situ hybridisation. Results: Following allergen challenge there was a significant increase in CD3+/CCR4+ cell numbers within the atopic group (p<0.001) and not in the non-atopics (p=0.28). Both atopics and non atopics showed an increase in CD3+/CXCR3+ cells at 48 hours after PPD challenge (p=0.01 and p=0.06 respectively). Furthermore IL-4 mRNA+ cells peaked at 8 hours after allergen challenge while IFNg mRNA+ cells were elevated after PPD challenge at 48 hours, with no change in the nonatopics. Conclusion: These data suggest that, in vivo, in man CCR4 recruits Th2 cells to the skin in the late response to specific allergen, whereas CXCR3 recruits Th1 cells to the skin in response to PPD challenge. Figure 6: IL-4 mRNA and IFN-γ mRNA expressing cells after (8hr & 48hr) allergen and PPD challenge BACKGROUND The recruitment of Th2 lymphocytes is recognised to play a central role in the pathogenesis of allergic conditions. Chemokine receptor expression on T cells has been shown to control both their cellular arrest within the vascular compartment through the up regulation of integrin molecules and their subsequent migration within the extravascular space. METHODS Figure 3: CD3+expressing CCR4 (8 hr) after Ag and PPD challenge CONCLUSIONS Figure 7: Relationship between IL-4 mRNA & CCR4 expressing cells and IFN-γ mRNA & CXCR3 expressing cells PATIENTS Sixteen atopics with summer hayfever, as defined by their history and positive skin prick test (median 8.0mm, IQ (5, 10)) to grass pollen were recruited to this study. The median age was 27 yrs (IQ, 24, 29) and M:F, 11:5. The serum concentrations of total IgE was (median 171IU/L ( IQ 42, 720)) and allergen specific IgE 24.0 IU/L (IQ 13, 79). Each subject underwent intradermal challenge to the extensor surface of the forearms with Tuberculin PPD (10 Tuberculin Units in 0.02ml), allergen (10 Biological Units in 0.02ml Phleum pratense or house dust mite extract) and diluent. The size of the late phase response was recorded eight and 48 hours after injection and a 4mm skin punch biopsy was taken under local anaesthetic. AIMS To determine: a) the expression of chemokine receptors CCR4 and CXCR3 on CD3+ cells in the skin following allergen and PPD challenge respectively b) IL-4 and IFN-γ mRNA expressing cells as putative markers of Th2 and Th1 cells, respectively CCR4 and CXCR3 on CD3+ Cells in the Skin following allergen and PPD challenge in atopic and non-atopic individuals SC Martins, GK Banfield, H Watanabe, KT Nouri-Aria, K Furukido, CM Lloyd, DS Robinson SR Durham Upper Respiratory Medicine, National Heart & Lung Institute, and Leukocyte Biology, Imperial College London, Manresa Road, London SW3 6LR, United Kingdom. Allergen Dil. 8 hrs 48 hrs 0 10 20 30 40 50 mRNA+cells/mm2 IL-4 IFN-γ PPD 0 5 10 15 20 Dil. 8 hrs 48 hrs mRNA+cells/mm2 IL-4 IFN-γ CD3+ /CXCR3+ CD3+ /CCR4+ Dual staining 0 20 40 60 80 100 Ag8 PPD8 Ag48 PPD48 %CCR4+ CXCR3+ cells %double %CXCR3 %CCR4 -20 0 20 40 60 80 CXCR3 +ve cells/mm2 0 10 20 30 IFN-γmRNA+vecells/mm2 r=0.61 p=0.03 Skin (PPD 48) 0 20 40 60 80 100 CCR4 +ve cells/mm 2 0 20 40 60 80 100 IL-4mRNA+vecells/mm2 r=0.64 p=0.01 Skin (Ag8) IL-4 mRNA vs CCR4 IFN-γ mRNA vs CXCR3 In a study of human cutaneous allergen-induced late responses (8hr) and tuberculin-induced delayed responses (48) hr, in which each subject acted as his/her own control: - CCR4 is increased on T cells at 8hr after allergen, correlates with IL-4 expression and is a phenotypic marker of Th2 cells - CXCR3 is increased on T cells at 48hrs after tuberculin challenge, correlates with IFN-γ expression and is a phenotypic marker of Th1 cells - These studies demonstrate that CCR4 is a potential therapeutic target for allergic diseases in man Table 1: CD3+/CCR4+, CD3+/CXCR3+ and cytokine mRNA expressing cells (IL-4 & IFN-γ)/mm2 Five micron acetone fixed sections were examined for the proportion of CD3+CCR4+, CD3+CXCR3+ and the co-expression of CCR4 and CXCR3 cells using dual immunofluorescence. Six micron paraformaldehyde sections were used for detection of IL-4 and IFN-γ mRNA expressing cells were determined by In situ hybridisation. STATISTICAL ANALYSIS Figure 5: %CCR4+, CXCR3+ and CCR4+CXCR3+ cells (8hr & 48hr) after Ag and PPD challenge The Mann-Whitney U test was used for comparison between allergen and PPD challenge. Wilcoxon Matched-pairs signed- rank test was used for within subject analysis. The Spearman rank test was used to correlate the numbers of IL-4 mRNA expressing cells with CCR4+ cells and IFN-γ mRNA expressing cells with CXCR3+ cells ACKNOWLEDGMENT This work is sponsored by Imperial College Trust Fund with the support of GlaxoSmithKline Figure 1: Skin section demonstrating CD3+CCR4+ cells (Ag 8hr) Figure 2: Skin section demonstrating CD3+CXCR3+ cells (PPD 48hr) Figure 4: CD3+expressing CXCR3 (48 hr) after Ag and PPD challenge Dil. Ag (8hr) Ag (48hr) P values Dil. PPD (8hr) PPD (48hr) P values CD3+ /CCR4+ cells 7.6±1.4 40.5±6*** 35±9.5** 0.000 0.009 18.7±7.7 7.7±1.6 53.8±13.6* 0.02 CD3+ /CXCR3+ cell 0.5±0.26 2.5±0.75* 0.8±0.45 0.04 0.7 3.9±3.4 1.3±0.47 20±5.6* 0.01 0.4 IL-4 mRNA+ cells 1.0±0.53 36.9±10.8* 19.9±8.5* 0.001 1.65±0.8 1.88±1.2 2.68±1.4 0.9 0.6 IFN-γ mRNA+ cells 0.57±0.2 6.5±1.1* 5.5±0.9* 0.001 0.001 0.44±0.2 1.7±0.5* 10.3±2.3** 0.03 0.003 Data are shown as mean±SEM Dil 48hr Ag 0 10 20 30 CD3+/CXCR3+cells/mm 2 Dil 48hr PPD p=0.7 p=0.03 p=002 (74) (57) (57) (55) Dil 8hr Ag 0 20 40 60 80 100 CD3+/CCR4+cells/mm 2 Dil 8hr PPD p=0.0000 p=0.1 p=0.000 (126)